IRadimed Corporation (IRMD) |
|
32.01 -1.2 (-3.61%)
|
06-26 22:34 |
|
Open: |
33.25 |
Pre. Close: |
33.21 |
|
High:
|
33.25 |
Low:
|
31.92 |
|
Volume:
|
93,524 |
Market Cap:
|
402(M) |
|
|
|
|
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
33.29 - 33.48 |
33.48 - 33.65 |
|
Low:
|
31.49 - 31.69 |
31.69 - 31.88 |
|
Close:
|
31.72 - 32.04 |
32.04 - 32.34 |
|
Technical analysis |
as of: 2022-06-24 4:40:56 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 40.05 One year: 46.77 |
| Support: |
Support1: 31.18 Support2: 29.26 |
| Resistance: |
Resistance1: 34.29 Resistance2: 40.05 |
| Pivot: |
32.35 |
| Moving Average: |
MA(5): 32.39 MA(20): 32.59
MA(100): 40.9 MA(250): 39.16  |
| MACD: |
MACD(12,26): -0.6 Signal(9): -0.8 |
| Stochastic oscillator: |
%K(14,3): 65.3 %D(3): 63.5 |
| RSI: |
RSI(14): 44.6 |
| 52-week: |
High: 55.91 Low: 28.67 |
| Average Vol(K): |
3-Month: 55 (K) 10-Days: 37 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ IRMD ] has closed above bottom band by 40.6%. Bollinger Bands are 61.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 26 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Sat, 25 Jun 2022
IRADIMED Names John F. Glenn Chief Financial Officer - GuruFocus.com
Thu, 23 Jun 2022
IRadimed Corporation (IRMD) Stock Price Today, Quote & News - Seeking Alpha
Sun, 19 Jun 2022
Analyzing IRadimed (NASDAQ:IRMD) and Quoin Pharmaceuticals (NASDAQ:QNRX) - Defense World
Tue, 14 Jun 2022
The total return for IRadimed (NASDAQ:IRMD) investors has risen faster than earnings growth over the last five years - Simply Wall St
Mon, 13 Jun 2022
Alpha Tau Medical (NASDAQ:DRTS) versus IRadimed (NASDAQ:IRMD) Financial Survey - Defense World
Wed, 01 Jun 2022
Perimeter Medical Imaging AI Appoints Experienced MedTech Executive, Chris Scott, as Chief Financial Officer - Yahoo Finance
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
12 (M) |
| Shares Float |
6 (M) |
|
% Held by Insiders
|
43.5 (%) |
|
% Held by Institutions
|
44 (%) |
|
Shares Short
|
165 (K) |
|
Shares Short P.Month
|
148 (K) |
Stock Financials |
|
EPS
|
0.47 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
5.5 |
|
Profit Margin (%)
|
23.2 |
|
Operating Margin (%)
|
24.7 |
|
Return on Assets (ttm)
|
9.6 |
|
Return on Equity (ttm)
|
16.6 |
|
Qtrly Rev. Growth
|
33.5 |
|
Gross Profit (p.s.)
|
2.59 |
|
Sales Per Share
|
3.63 |
|
EBITDA (p.s.)
|
1.02 |
|
Qtrly Earnings Growth
|
80 |
|
Operating Cash Flow
|
12 (M) |
|
Levered Free Cash Flow
|
9 (M) |
Stock Valuations |
|
PE Ratio
|
66.68 |
|
PEG Ratio
|
1.7 |
|
Price to Book value
|
5.81 |
|
Price to Sales
|
8.79 |
|
Price to Cash Flow
|
33.64 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
